Raymond James & Associates’s Assertio ASRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-301
Closed -$451K 3247
2016
Q3
$451K Sell
301
-48
-14% -$60.3K ﹤0.01% 2358
2016
Q2
$411K Buy
349
+9
+3% +$9.84K ﹤0.01% 2212
2016
Q1
$284K Buy
340
+146
+75% +$135K ﹤0.01% 2365
2015
Q4
$211K Buy
+194
New +$218K ﹤0.01% 2305
2015
Q3
Sell
-180
Closed -$232K 2263
2015
Q2
$232K Buy
180
+10
+6% +$13.7K ﹤0.01% 2346
2015
Q1
$229K Buy
+170
New +$209K ﹤0.01% 2289

Other funds holding ASRT

Raymond James & Associates's ASRT Position: Q4 2016 in Review

Raymond James & Associates sold out of Assertio (ASRT) in Q4 2016, closing a stake of 301 shares — an estimated $451K sold.

Raymond James & Associates first reported a position in ASRT in Q1 2015 and held it in 6 quarters. The position peaked at $451K in Q3 2016. 204 funds tracked by Wall St. Rank hold ASRT as of Q4 2016.

  • Raymond James & Associates reported no remaining Assertio position as of Q4 2016 after selling out during the quarter.
  • Raymond James & Associates sold 301 Assertio shares in Q4 2016, an estimated $451K.
  • Raymond James & Associates first reported a position in Assertio in Q1 2015 and held it in 6 quarters.
  • Raymond James & Associates's Assertio position peaked at $451K in Q3 2016.
  • 204 funds tracked by Wall St. Rank held Assertio as of Q4 2016.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.